Skip to content
Open access

Clinical Significance of Lipoprotein and Ceruloplasmin Variations in Type 2 Diabetes Mellitus: A Cross-Sectional Study in Owo, Nigeria

Jul 2026 · Rwanda Journal of Medicine and Health Sciences · Vol 9, pp. 299 - 310 · 0 citations · 30 references
Medicine

TL;DR

Ceruloplasmin was raised in T2DM, dyslipidemia, and lowered antioxidant capability were early markers that prompt intervention for oxidative stress and biochemical derangements in patients with T2DM.

Abstract

Background Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance leading to hyperglycemia, dyslipidemia, and oxidative stress. Ceruloplasmin (CP), the major oxidase and copper-binding protein, has recently been under investigation as an indicator of metabolic dysfunction. Increased CP levels cause oxidative stress and inflammation and thus promote numerous cardiovascular and renal complications. Determination of CP could serve as an early reliable biomarker for timely intervention in the holistic management of T2DM. The present study was designed to compare lipoprotein levels, CP, and oxidative stress markers between participants with diabetes and those without diabetes. Methods Fifty patients with T2DM were evaluated along with 30 age- and sex-matched non-diabetic controls visiting Federal Medical Centre, Owo. Standard enzymatic and ELISA techniques assessed biochemical parameters such as fasting blood sugar (FBS), total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), very low-density lipoprotein (VLDL), CP, malondialdehyde (MDA), and total antioxidant status (TAS). Data were analyzed by SPSS Version 25. The independent t-test was then used to determine the difference between group means in the biochemical markers. Spearman's correlation was applied to establish relationships, and the level of significance was set at p<0.05. Results The FBS, CP, TC, TG, HDL, VLDL, and MDA levels were all statistically significant in patients with T2DM, while TAS decreased remarkably (p<0.05). Obese participants showed exacerbated dyslipidemia and oxidative stress. Positive correlations were observed between CP and lipid parameters, while MDA negatively correlated with TAS. Conclusion Ceruloplasmin was raised in T2DM, dyslipidemia, and lowered antioxidant capability were early markers that prompt intervention for oxidative stress and biochemical derangements in patients with T2DM. In this regard, CP could potentially emerge as a novel marker to monitor the progression of complications in T2DM.

Read PDF

Similar papers

Oct 2026

Diagnostic Value of Atherogenic Indices and Serpin B 13 in Iraqi Type II Diabetic Patients

Background: Type 2 diabetes mellitus (T2DM) is one of the most common chronic metabolic diseases and is characterized by insulin resistance accompanied by progressive pancreatic beta-cell dysfunction. Alterations in lipid metabolism and emerging circulating biomarkers may provide additional information regarding the me...

Saif Darwish, Shakir F. T. Alaaraji · 0 citations
Open access Sep 2026

Dyslipidemia as a Predictor of Liver Dysfunction, Glycaemic Control and Insulin Resistance: A Cross-Sectional Study

Dyslipidemia (DL), a common metabolic disorder, negatively influences the regulation of glycemia, liver function and insulin sensitivity and is a crucial factor in the dramatic increase in metabolic diseases. In India, the prevalence ranges from 15–20% in rural populations to 25–30% indicating the wide-spread prevalenc...

Naveen Kumar Billa, Darapuneni Radhika Chowdary, Sainath S. B. et al. · 0 citations
Open access Oct 2026

Evaluation of Antioxidant Status in Type 2 Diabetes Patients Attending Madonna University Teaching Hospital

Type 2 diabetes mellitus (T2DM) is a chronic metabolic condition characterised by persistent hyperglycemia, insulin resistance and increasing pancreatic β-cell dysfunction. Increased oxidative stress and poor antioxidant defense are critical factors implicated in the development and progression of diabetes problems. Th...

A. O. Mba, O. Dike, Ibeh Rhoda Ifechukwu · 0 citations
Open access Sep 2026

Comparative Assessment of Metabolic, Oxidative Stress and Inflammatory Biomarkers in Type 2 Diabetes Mellitus

Diabetes mellitus is a chronic metabolic illness characterized by persistent hyperglycemia and complex biochemical disequilibrium in carbohydrate, lipid, and protein metabolism. The objective of this research was to investigate the biochemical pathways of diabetes mellitus by evaluating metabolic and oxidative stress a...

A. Zerjawi, Mohammed Challoob Murad · 0 citations
Open access Sep 2026

Correlation Between Vitamin D3, Atherogenic Indices of Plasma and Cardiometabolic Biomarkers in Diabetic Patients

Background: Cardiometabolic disease is a cluster of interconnected cardiovascular and metabolic disorders. These include obesity, insulin resistance, hypertension, heart disease and type 2 diabetes. In this study, focus was to identify correlation between serum vitamin D3 levels along with Atherogenic Indices of Plasma...

Urooj Ata, Noor-ul-Huda Raja, S. Malik et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.